Forian (FORA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Dec, 2025Executive summary
A special meeting is scheduled for January 8, 2026, to vote on redomiciling from Delaware to Maryland and to approve potential adjournments if more proxy votes are needed.
The redomiciliation is intended to facilitate consideration of a take-private offer and other strategic alternatives, removing Delaware's Section 203 anti-takeover restrictions.
The Board, following a Special Committee's recommendation, unanimously supports the redomiciliation and adjournment proposals.
The Consortium, holding 66.5% of shares, has indicated support, ensuring passage of both proposals.
Voting matters and shareholder proposals
Proposal 1 seeks approval to redomicile to Maryland via statutory conversion.
Proposal 2 allows adjournment of the meeting to solicit more proxies if needed for Proposal 1.
The Board recommends voting FOR both proposals.
No other business is expected at the meeting.
Shareholder proposals for the 2026 annual meeting must be submitted between December 30, 2025, and January 29, 2026.
Board of directors and corporate governance
The Special Committee, composed of independent directors, led the evaluation of the redomiciliation and strategic alternatives.
The Board will remain classified, with staggered three-year terms, and the number of directors can be up to 15.
Maryland articles and bylaws closely mirror Delaware's, with some differences in director removal and shareholder rights.
The Special Committee retains authority through the completion of any potential transaction.
Latest events from Forian
- Q2 revenue fell 2% to $4.8M, net loss widened, and 2024 guidance was lowered.FORA
Q2 20241 Feb 2026 - Q3 2024 revenue fell 12% to $4.7M; Kyber acquisition and sales momentum set up future growth.FORA
Q3 202414 Jan 2026 - Re-domiciliation from Delaware to Maryland approved by majority stockholder vote.FORA
EGM 20268 Jan 2026 - Redomiciliation to Maryland is proposed to enable a take-private offer, with majority support assured.FORA
Proxy Filing4 Dec 2025 - Annual meeting to vote on director elections, equity plan expansion, and auditor ratification.FORA
Proxy Filing1 Dec 2025 - Key votes include director elections, equity plan expansion, and auditor ratification.FORA
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 45% to $7.1M, with narrowed net loss and strong 2025 growth outlook.FORA
Q1 202526 Nov 2025 - Q2 2025 revenue up 57% to $7.5M, with positive net income and strong outlook for 2025.FORA
Q2 202523 Nov 2025 - Q3 2025 revenue surged 66% to $7.8M, with improved margins and strong year-end outlook.FORA
Q3 202517 Nov 2025